Chondrocyte therapeutic delivery system
US7897384B2 · kind B2 · utility
19Cited by
64References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2003 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Nov 15, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for producing therapeutic agents using chondrocytes are provided. The genetically engineered chondrocytes can be used to express the therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.